يعرض 1 - 20 نتائج من 92 نتيجة بحث عن '"Mahato, Arun Kumar"', وقت الاستعلام: 0.53s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    المساهمون: Institute of Biotechnology, Mart Saarma / Principal Investigator

    وصف الملف: application/pdf

    Relation: The presented work was kindly supported by the General Research Fund (12102020 and 22104123) (Wong HLX), Health and Medical Research Fund (08793626) (Wong HLX), Excellent Young Scientist Fund by National Natural Science Foundation of China (32322091) (Wong HLX) and Innovation and Technology Fund (ITS/058/22MS) (Wong HLX).; Guo , X , Asthana , P , Zhai , L , Cheng , K W , Gurung , S , Huang , J , Wu , J , Zhang , Y , Mahato , A K , Saarma , M , Ustav , M , Kwan , H Y , Lyu , A , Chan , K M , Xu , P , Bian , Z-X & Wong , H L X 2024 , ' Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis ' , Nature Communications , vol. 15 , 1034 . https://doi.org/10.1038/s41467-024-45452-3; ORCID: /0000-0001-5543-7160/work/156157546; http://hdl.handle.net/10138/573428; 6ee211f4-a4ad-461d-b973-aa5075029bdb; 001156769400017

  3. 3
    Academic Journal
  4. 4
    Academic Journal

    المساهمون: Institute of Biotechnology, Helsinki Institute of Life Science HiLIFE, Joint Activities, Helsinki Institute of Life Science HiLIFE, Divisions of Faculty of Pharmacy, Helsinki Institute of Sustainability Science (HELSUS), Polymers, Department of Chemistry, Faculty of Science

    وصف الملف: application/pdf

    Relation: M.S.H. is grateful to the higher education commission of Pakistan and German academic exchange services (HECDAAD Pakistan) for the award of his Ph.D. scholarship. Y.S. acknowledges financial support from the Academy of Finland (grant numbers 1325555 and N 1333697). This work was supported by Deutsche Forschungsgemeinschaft (DFG), German Research Foundation Project no. 398461692 awarded to R.L. We also thank Jan Weichhold for providing technical support during XRD measurements. We are grateful to Paula Collin for her excellent technical assistance with cell-based assays and to Pharmidex Pharmaceutical Services Ltd. (U.K.) for the measurement of the plasma and brain concentration of BT44. We further thank the NMR core facility supported by University of Helsinki, Biocenter Finland and Helsinki Institute of Life Science (HiLIFE) for verification of the structure of BT44. The table of contents graphic for this article was created with BioRender.com.; Haider , M S , Mahato , A K , Kotliarova , A , Forster , S , Böttcher , B , Stahlhut , P , Sidorova , Y & Luxenhofer , R 2023 , ' Biological Activity In Vitro, Absorption, BBB Penetration, and Tolerability of Nanoformulation of BT44 : RET Agonist with Disease-Modifying Potential for the Treatment of Neurodegeneration ' , Biomacromolecules , vol. 24 , no. 10 , pp. 4348–4365 . https://doi.org/10.1021/acs.biomac.2c00761; ORCID: /0000-0001-5567-7404/work/147400682; http://hdl.handle.net/10138/567397; 7f827a91-32f5-46ae-b1e8-ea84fea7b39a; 85139829855; 000869074200001

  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal

    المساهمون: Regenerative pharmacology group, Regenerative Neuroscience, Division of Pharmacology and Pharmacotherapy, Institute of Biotechnology, Helsinki Institute of Life Science HiLIFE, Drug Research Program, Divisions of Faculty of Pharmacy, Mart Saarma / Principal Investigator

    وصف الملف: application/pdf

    Relation: This work was supported by FP7-HEALTH-2013-INNOVATION-1 GA N602919, FP7-PEOPLE-2013-IAPP GA N612275, Gene Code Ltd., Lundbeck Foundation, Sigrid Jusélius Foundation (MS), Parkinson’s UK Innovation grant - K-1408 (MS and YAS), Academy of Finland Project Grant 1325555 (YAS). Academy of Finland Grants 126744, 309708 and 314233 (MV). Centre of Excellence in Molecular Cell Engineering, Estonia, 2014-2020.4.01.15-013 (MK), Finnish Parkinson’s Foundation fellowship (AKM) and The Finnish Funding Agency for Innovation (Tekes, 3iRegeneration, Project 40395/13) (RKT and MS).; Renko , J-M , Mahato , A K , Visnapuu , T , Valkonen , K , Karelson , M , Voutilainen , M H , Saarma , M , Tuominen , R K & Sidorova , Y A 2021 , ' Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats ' , Journal of Parkinson's disease , vol. 11 , no. 3 , pp. 1023-1046 . https://doi.org/10.3233/JPD-202400; ORCID: /0000-0002-9614-1988/work/99386290; ORCID: /0000-0001-5543-7160/work/99387628; http://hdl.handle.net/10138/333936; 54e9b2ee-4d2b-4b8e-afbc-dfd914eeb6cc; 000683027900011

  11. 11
    Academic Journal

    المساهمون: Institute of Biotechnology

    وصف الملف: application/pdf

    Relation: Current work was financially supported by FP7-PEOPLE-2013-IAPP GA N612275, Parkinson's UK Innovation Grant K-1408 and Russian Foundation for Basic Research (Grant No 19-03-00071a). We thank Jenni Montonen and Elena Burtovskaia for their excellent assistance with experimental procedures. We thank Prof. Mart Saarma for critical comments to this paper.; Ardashov , O V , Pavlova , A V , Mahato , A K , Sidorova , Y , Morozova , E A , Korchagina , D V , Salnikov , G E , Genaev , A M , Patrusheva , O S , Li-Zhulanov , N S , Tolstikova , T G , Volcho , K P & Salakhutdinov , N F 2019 , ' A Novel Small Molecule Supports the Survival of Cultured Dopamine Neurons and May Restore the Dopaminergic Innervation of the Brain in the MPTP Mouse Model of Parkinson's Disease ' , ACS chemical neuroscience , vol. 10 , no. 10 , pp. 4337-4349 . https://doi.org/10.1021/acschemneuro.9b00396; http://hdl.handle.net/10138/322044; 4701bf34-8253-483b-a462-1942d69e4980; 000491219000017

  12. 12
    Academic Journal

    المساهمون: Department of Pharmacology, Faculty of Medicine, University of Helsinki, INDIVIDRUG - Individualized Drug Therapy, Research Programs Unit, Institute of Biotechnology, HUSLAB, Medicum, Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Nanomedicines and Biomedical Engineering, Helsinki One Health (HOH), Divisions of Faculty of Pharmacy, Helsinki Institute of Life Science HiLIFE, Pekka Rauhala / Principal Investigator, HUS Perioperative, Intensive Care and Pain Medicine, Eija Kalso / Principal Investigator, Department of Diagnostics and Therapeutics, Anestesiologian yksikkö, Helsinki University Hospital Area

    وصف الملف: application/pdf

    Relation: Viisanen , H , Nuotio , U , Kambur , O , Mahato , A K , Jokinen , V , Lilius , T , Li , W , Santos , H A , Karelson , M , Rauhala , P , Kalso , E & Sidorova , Y A 2020 , ' Novel RET agonist for the treatment of experimental neuropathies ' , Molecular pain , vol. 16 , 1744806920950866 . https://doi.org/10.1177/1744806920950866; RIS: urn:989CF69CD1F7E1CAEA95BA2C1E779E7A; ORCID: /0000-0003-2036-3522/work/80576319; ORCID: /0000-0002-6997-9611/work/80578846; ORCID: /0000-0001-7850-6309/work/103469474; http://hdl.handle.net/10138/319451; b4a7fa72-b172-46ea-82e7-1c987c3564e3; 000563365700001

  13. 13
    Academic Journal

    المساهمون: Institute of Biotechnology, Helsinki Institute of Life Science HiLIFE, Division of Pharmacology and Pharmacotherapy, Regenerative pharmacology group, Regenerative Neuroscience, Centre of Excellence in Stem Cell Metabolism, STEMM - Stem Cells and Metabolism Research Program, Drug Research Program, Timo Petteri Piepponen / Principal Investigator, Mart Saarma / Principal Investigator

    وصف الملف: application/pdf

    Relation: The current work was financially supported by FP7-HEALTH-2013-INNOVATION-1 GA N602919, FP7-PEOPLE-2013-IAPP GA N612275, Genecode Ltd, Lundbeck Foundation, Sigrid Juselius Foundation (all to M.S.), Parkinson's UK Innovation Grant K-1408 to M.S. and Y.A.S., Academy of Finland Project Grant 1325555 to Y.A.S., Academy of Finland Grants 293392 and 319195 to A.D., Academy of Finland Grants 126744, 309708 and 314233 to M.H.V. Centre of Excellence in Molecular Cell Engineering, Estonia, 2014-2020.4.01.15-013, Grant PUT582 from the Estonian Research Council to M.K., Finnish Parkinson's Foundation fellowship to A.K.M., and The Finnish Funding Agency for Innovation (TEKES, 3iRegeneration, Project 40395/13) to R.K.T. and M.S.; Mahato , A K , Kopra , J , Renko , J-M , Visnapuu , T , Korhonen , I , Pulkkinen , N , Bespalov , M M , Domanskyi , A , Ronken , E , Piepponen , T P , Voutilainen , M H , Tuominen , R K , Karelson , M , Sidorova , Y A & Saarma , M 2020 , ' Glial cell line-derived neurotrophic factor receptor REarranged during transfection agonist supports dopamine neurons in Vitro and enhances dopamine release In Vivo ' , Movement Disorders , vol. 35 , no. 2 , pp. 245-255 . https://doi.org/10.1002/mds.27943; ORCID: /0000-0002-2318-1612/work/71512044; ORCID: /0000-0002-9614-1988/work/71512624; ORCID: /0000-0001-5543-7160/work/71513963; ORCID: /0000-0002-8754-5753/work/71513967; ORCID: /0000-0002-4872-3326/work/159449492; http://hdl.handle.net/10138/320194; 2c976ce8-60e8-425a-ac32-4b2372b20aca; 000502663800001

  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20

    المؤلفون: Mahato, Arun Kumar

    المساهمون: University of Helsinki, Faculty of Biological and Environmental Sciences, Institute of Biotechnology, HiLIFE, Doctoral Programme Brain and Mind, Helsingin yliopisto, bio- ja ympäristötieteellinen tiedekunta, Aivot ja mieli tohtoriohjelma (B&M), Helsingfors universitet, bio- och miljövetenskapliga fakulteten, Doktorandprogrammet i hjärn- och medvetandeforskning, Kokaia, Zaal, Sidorova, Yulia, Saarma, Mart

    مصطلحات موضوعية: physiology and Neuroscience

    وصف الملف: application/pdf